Séquelles respiratoires liées au Covid-19 : dépistage et prise en charge [Covid-19 respiratory sequelae : Screening and management]
Fiche du document
17 novembre 2021
- doi: 10.53738/REVMED.2021.17.759.1992
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.759.1992
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/34787974
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_4245B1C7DF802
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Lung Infectious diseases Physical activity Warm-up Workouts (Exercise)Citer ce document
M.K. Truong et al., « Séquelles respiratoires liées au Covid-19 : dépistage et prise en charge [Covid-19 respiratory sequelae : Screening and management] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.759.1992
Métriques
Partage / Export
Résumé
Infection with SARS-CoV-2 can affect multiple organ systems with variable severity and is known to frequently have a major impact on the respiratory system. Symptoms may persist for several months after infection, and are associated with a reduction of lung function, diminished exercise capacity and anomalies on chest CT. Guidelines on the post-acute care of patients with SARS-CoV-2 are now available. Pulmonary rehabilitation plays a central role in the recovery of exercise capacity, notably in severe cases. The role of specific therapies, such as corticosteroids, anti-fibrotics and lung transplantation remains uncertain and needs to be evaluated on a case-by-case basis.